SCPS — Scopus Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Scopus Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.002	0.037	1.83	7.94	0.125
Net Total Receivables	0.028	0.001	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.133	0.768	1.97	8.18	0.39
Net Property, Plant And Equipment	—	0.004	0.002	0.003	0.002
Total Assets	0.133	0.772	1.97	8.19	0.392
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.138	0.855	3.81	4.17	7.45
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	0.138	0.855	3.81	4.17	6.96
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.005	-0.083	-1.83	4.02	-6.56
Total Liabilities & Shareholders' Equity	0.133	0.772	1.97	8.19	0.392
Total Common Shares Outstanding